CASTLE BIOSCIENCES
Castle Biosciences is a biotech company that develops and validates diagnostic tests and technologies for the treatment of cancer. The company also focused on providing physicians and patients with personalized, clinically actionable genomic information to make more accurate treatment plan decisions. The DecisionDx family of molecular diagnostic tests have the ability to meaningfully impact how cancers are diagnosed and managed and the DecisionDx-Melanoma predicts risk of recurrence or metastasis for patients with invasive cutaneous melanoma, a deadly skin cancer, including the risk of sentinel lymph node positivity. Castle Biosciences was founded in 2008 and is headquartered in Friendswood, Texas, United States.
CASTLE BIOSCIENCES
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2008-01-01
Address:
Friendswood, Texas, United States
Country:
United States
Website Url:
http://www.castlebiosciences.com
Total Employee:
251+
Status:
Active
Contact:
602-535-1997
Total Funding:
354.27 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Current Advisors List
Board_member
Board_member
2012-01-01
Current Employees Featured
Derek Maetzold President, CEO & Founder @ Castle Biosciences
President, CEO & Founder
2008-05-01
Federico Monzon Chief Medical Officer @ Castle Biosciences
Chief Medical Officer
2015-11-01
Castle Biosciences Chief Business Officer & Chief Operating Officer @ Castle Biosciences
Chief Business Officer & Chief Operating Officer
2016-05-01
Sherri Borman Laboratory Director @ Castle Biosciences
Laboratory Director
2018-10-01
Frank Stokes Chief Financial Officer @ Castle Biosciences
Chief Financial Officer
2017-12-01
Kristen Oelschlager Chief Operations Officer @ Castle Biosciences
Chief Operations Officer
2020-09-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-04-04 | AltheaDx | AltheaDx acquired by Castle Biosciences | 65 M USD |
| 2021-10-19 | Cernostics | Cernostics acquired by Castle Biosciences | 30 M USD |
| 2021-04-27 | MyPath Melanoma | MyPath Melanoma acquired by Castle Biosciences | 32.5 M USD |
Investors List
Spindletop Capital Management
Spindletop Capital Management investment in Venture Round - Castle Biosciences
BrightEdge Fund
BrightEdge Fund investment in Convertible Note - Castle Biosciences
MGC Venture Partners
MGC Venture Partners investment in Venture Round - Castle Biosciences
BioBrit
BioBrit investment in Venture Round - Castle Biosciences
Sofinnova Partners
Sofinnova Partners investment in Venture Round - Castle Biosciences
Industry Ventures
Industry Ventures investment in Venture Round - Castle Biosciences
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - Castle Biosciences
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Castle Biosciences
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Castle Biosciences
Industry Ventures
Industry Ventures investment in Series F - Castle Biosciences
Official Site Inspections
http://www.castlebiosciences.com Semrush global rank: 1.58 M Semrush visits lastest month: 16.2 K
- Host name: a3ef2d3a3279c65d0.awsglobalaccelerator.com
- IP address: 76.223.88.164
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Castle Biosciences"
About Us | Castle Biosciences
Who we are. We are an innovator in proprietary laboratory-developed tests, which provide personalized, clinically actionable information that can help healthcare providers and patients make more informed disease management decisions.See details»
Castle Biosciences | Innovative Molecular Diagnostics
This study is a prospective, multi-center study that assessed the effect of 31-GEP testing on SLNB performance rates in patients with T1–T2 tumors considering SLNB and to study long …See details»
Leadership - Castle Biosciences
Vice President, Marketing and brand manager, uveal melanoma (um) Read moreSee details»
Castle Biosciences Inc. - Investor Relations
Annual Report. 2024 was another year of strength for Castle. Fueled by our steadfast commitment to improving patient care, we navigated a dynamic reimbursement and regulatory landscape while delivering exceptional …See details»
Castle Biosciences, Inc. | LinkedIn
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping ...See details»
Castle Biosciences - Crunchbase Company Profile & Funding
Castle Biosciences is a biotech company that develops and validates diagnostic tests and technologies for the treatment of cancer. The company also focused on providing physicians …See details»
Castle Biosciences - Overview, News & Similar companies
May 26, 2024 Castle Biosciences contact info: Phone number: (866) 788-9007 Website: www.castlebiosciences.com What does Castle Biosciences do? Castle Biosciences develops …See details»
Castle Biosciences
Clinician Ordering Portal Improving health through innovative tests that guide patient careSee details»
Castle Biosciences - Craft
Oct 29, 2024 Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers. It offers products for diagnosing cutaneous …See details»
Castle Biosciences (CSTL) Company Profile & Description - Stock …
Jul 25, 2019 505 S. Friendswood Drive, Suite 401 Friendswood, Texas 77546 United StatesSee details»
Careers - Castle Biosciences
I love the people here at Castle and being a part of an organization that works together to make a difference in patients’ lives. As we continue to grow, it is exciting to be a part of the …See details»
Castle Biosciences Inc. - Castle Biosciences Honored with a Top ...
FRIENDSWOOD, Texas, April 07, 2025 (GLOBE NEWSWIRE) - Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, …See details»
The True Test of Success | BOSS Magazine
Dec 19, 2024 Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform …See details»
Working at Castle Biosciences - Top Workplaces
A career at Castle Biosciences means working at a people-first organization, proven by employee feedback data. ... please visit www.CastleBiosciences.com and connect with us on LinkedIn, …See details»
Castle Biosciences Inc. - Investor Relations
Feb 27, 2025 Founded in 2008, Castle Biosciences is a leading molecular diagnostics company focused on improving health through innovative tests that guide patient care.See details»
Corporate Responsibility | Castle Biosciences
Castle Biosciences was founded on the guiding principle of doing the right thing at the right time. Our focus on corporate responsibility began with this guiding principle in 2008, when we laid …See details»
Castle Biosciences to Acquire Previse - GlobeNewswire
18 hours ago czuckero@castlebiosciences.com. Tags CSTL M&A. Recommended Reading. May 05, 2025 16:06 ET | Source: Castle Biosciences, Inc. Castle Biosciences Reports First …See details»
Castle Biosciences Inc. - Publication of Data from Prospective ...
Through December 31, 2024, DecisionDx-Melanoma has been ordered approximately 191,800 times for patients diagnosed with cutaneous melanoma. Learn more at …See details»
Castle Biosciences to Acquire Previse
1 day ago Expected to complement Castle’s current gastroenterology franchise Adds methylation technology developed at the Johns Hopkins University School of Medicine and …See details»
Castle Biosciences to Acquire Previse - Yahoo Finance
18 hours ago Expected to complement Castle’s current gastroenterology franchise Adds methylation technology developed at the Johns Hopkins University School of Medicine and …See details»